Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


27.03.2017

12 AIDS
9 AIDS Res Hum Retroviruses
1 Ann Intern Med
1 Antimicrob Agents Chemother
2 Antivir Ther
17 Clin Infect Dis
2 HIV Med
1 Int J Dermatol
9 J Acquir Immune Defic Syndr
9 J Infect Dis
1 J Med Virol
4 J Virol
1 JAMA
1 Lancet
1 Lancet Diabetes Endocrinol
1 MMWR Morb Mortal Wkly Rep
1 Nature
1 Pediatr Infect Dis J
11 PLoS One
3 PLoS Pathog
1 Proc Natl Acad Sci U S A
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MUKANDAVIRE C, Low A, Mburu G, Trickey A, et al
    Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001458.
    PubMed     Text format     Abstract available

  2. GAGNEUX-BRUNON A, Rochereau N, Botelho-Nevers E, Lucht F, et al
    Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001460.
    PubMed     Text format     Abstract available

  3. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in men who have sex with men: a prospective cohort study.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001451.
    PubMed     Text format     Abstract available

  4. MONTGOMERY ET, van der Straten A, Chitukuta M, Reddy K, et al
    "It's inside my body and it's mine".
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001452.
    PubMed     Text format     Abstract available

  5. MOORE CB, Capparelli EV, Samson P, Bwakura-Dangarembizi M, et al
    CYP2B6 Genotype-directed dosing is required for optimal efavirenz exposure in children 3 to 36 months with HIV infection.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001463.
    PubMed     Text format     Abstract available

  6. SAMUELS R, Bayerri CR, Sayer JA, Price DA, et al
    TDF associated renal tubular dysfunction: non-invasive assessment of mitochondrial injury.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001466.
    PubMed     Text format     Abstract available

  7. JIN F, Roberts JM, Grulich AE, Poynten IM, et al
    The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001462.
    PubMed     Text format     Abstract available

  8. ROBBINS HA, Strickler HD, Massad LS, Pierce CB, et al
    Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001450.
    PubMed     Text format     Abstract available

  9. OZANNE A, Duffau P, Dauchy FA, Rigothier C, et al
    Activation, senescence and inflammation markers in HIV patients: association with renal function.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001461.
    PubMed     Text format     Abstract available

  10. MEIJIDE H, Pertega S, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Increased incidence of cancer observed in HIV/HCV-coinfected patients versus HIV-monoinfected, 1993-2014.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001448.
    PubMed     Text format     Abstract available

  11. PRICE H, Dunn D, Zachary T, Vudriko T, et al
    Hepatitis B serological markers and plasma DNA concentrations: baseline results from the DART trial.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001454.
    PubMed     Text format     Abstract available

  12. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    HCV drives increased type I IFN-associated impairments associated to fibrosis severity in ART-treated HIV-1-HCV coinfected individuals.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001455.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  13. MABEYA SN, Ngugi CW, Lihana RW, Khamadi SA, et al
    Predominance of Hepatitis B Virus genotype A among treated HIV infected patients experiencing high HBV drug resistance in Nairobi, Kenya.
    AIDS Res Hum Retroviruses. 2017 Mar 19. doi: 10.1089/AID.2017.0019.
    PubMed     Text format     Abstract available

  14. YELIGAR SM, Ward JM, Harris FL, Brown LA, et al
    Dysregulation of alveolar macrophage PPARgamma, NADPH oxidases and TGFbeta<sub>1</sub> in otherwise healthy HIV-infected individuals.
    AIDS Res Hum Retroviruses. 2017 Mar 17. doi: 10.1089/AID.2016.0030.
    PubMed     Text format     Abstract available

  15. SCHLUSSER KE, Konikoff J, Kirkpatrick AR, Morrison C, et al
    Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.
    AIDS Res Hum Retroviruses. 2017 Mar 20. doi: 10.1089/aid.2016.0245.
    PubMed     Text format     Abstract available

  16. WIRUNSAWANYA K, Belyea L, Shikuma C, Watanabe R, et al
    Plasminogen Activator Inhibitor -1 (PAI-1) Predicts Negative Alterations in Whole Body Insulin Sensitivity in Chronic HIV Infection.
    AIDS Res Hum Retroviruses. 2017 Mar 21. doi: 10.1089/AID.2016.0292.
    PubMed     Text format     Abstract available

  17. TASSIOPOULOS K, Huo Y, Braun J, Williams PL, et al
    Blood lead levels and neurodevelopmental function in perinatally HIV-exposed, uninfected children in a US-based longitudinal cohort study.
    AIDS Res Hum Retroviruses. 2017 Mar 21. doi: 10.1089/AID.2016.0265.
    PubMed     Text format     Abstract available

  18. JAN M, Upadhyay C, Sharma A, Hioe CE, et al
    Manalpha1-2Man binding anti-HIV lectins enhance the exposure of V2i and V3 crown neutralization epitopes on the V1V2 and V3 hypervariable loops of HIV-1 Envelope.
    AIDS Res Hum Retroviruses. 2017 Mar 21. doi: 10.1089/AID.2016.0262.
    PubMed     Text format     Abstract available

  19. DELATORRE E, Couto-Fernandez JC, Bello G
    HIV-1 Genetic Diversity in Northeastern Brazil: high prevalence of non-B subtypes.
    AIDS Res Hum Retroviruses. 2017 Mar 22. doi: 10.1089/AID.2017.0045.
    PubMed     Text format     Abstract available

  20. HAO M, Wang J, Xin R, Li X, et al
    Low Rates of Transmitted Drug Resistances Among Treatment-naive HIV-1 Infected Students in Beijing, China.
    AIDS Res Hum Retroviruses. 2017 Mar 22. doi: 10.1089/AID.2017.0053.
    PubMed     Text format     Abstract available

  21. MEYERHOFF RR, Scearce RM, Ogburn DF, Lockwood B, et al
    HIV-1 consensus envelope-induced broadly binding antibodies.
    AIDS Res Hum Retroviruses. 2017 Mar 17. doi: 10.1089/AID.2016.0294.
    PubMed     Text format     Abstract available


    Ann Intern Med

  22. FALADE-NWULIA O, Suarez-Cuervo C, Nelson DR, Fried MW, et al
    Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.
    Ann Intern Med. 2017 Mar 21. doi: 10.7326/M16-2575.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  23. HUBER AD, Michailidis E, Tang J, Puray-Chavez MN, et al
    3-hydroxypyrimidine-2,4-diones as novel hepatitis B virus antivirals targeting the viral ribonuclease H.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.00245.
    PubMed     Text format     Abstract available


    Antivir Ther

  24. ECKARD AR, Rosebush JC, O'Riordan MA, Graves CC, et al
    Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.
    Antivir Ther. 2017 Mar 22. doi: 10.3851/IMP3157.
    PubMed     Text format     Abstract available

  25. OLIVEIRA VH, Wiechmann SL, Narciso AM, Webel AR, et al
    Muscle strength is impaired in men but not in women living with HIV taking antiretroviral therapy.
    Antivir Ther. 2017 Mar 22. doi: 10.3851/IMP3159.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  26. BERSHETYN A, Odeny TA, Lyamuya R, Nakiwogga-Muwanga A, et al
    The causal effect of tracing by peer health workers on return to clinic among patients who were lost to follow-up from antiretroviral therapy in eastern Africa: a randomized "natural experiment" arising from surveillance of lost patients.
    Clin Infect Dis. 2017 Mar 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. NEGOESCU DM, Zhang Z, Bucher HC, Bendavid E, et al
    Differentiated HIV Rna Viral Load Monitoring in Resource Limited Settings: An Economic Analysis.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. UPRETY P, Patel K, Karalius B, Ziemniak C, et al
    HIV-1 DNA Decay Dynamics with Early, Long-term Virologic Control of Perinatal Infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available

  30. CEPEDA JA, Thomas DL, Astemborski J, Sulkowski MS, et al
    Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Text format     Abstract available

  31. KUGATHASAN R, Collier DA, Haddow LJ, El Bouzidi K, et al
    Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  32. BORGES AH, Hoy J, Florence E, Sedlacek D, et al
    Antiretrovirals, fractures and osteonecrosis in a large international HIV cohort.
    Clin Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. PARKER RA, Rabideau DJ, Sax PE, Tierney C, et al
    The Impact of Medication Adherence on Virologic Failure in A5202, A Randomized, Partially-Blinded, Phase 3B Study.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available

  34. ELUL B, Saito S, Chung H, Hoos D, et al
    Attrition from HIV treatment programs in Africa: A longitudinal ecological analysis using data from 307,144 patients initiating antiretroviral therapy between 2005 and 2010.
    Clin Infect Dis. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available

  35. PROANO A, Bravard MA, Lopez JW, Lee GO, et al
    Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available

  36. VIBHOLM L, Schleimann MH, Hojen JF, Benfield T, et al
    Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available

  37. CYKTOR JC, Mellors JW
    TLR Agonists: Can They Exact a Toll on HIV Persistence?
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format    

  38. HERRICK JA, Legrand F, Gounoue R, Nchinda G, et al
    Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  39. LAKE JE, Stanley T, Apovian C, Bhasin S, et al
    Practical Review of Recognition and Management of Obesity and Lipohypertrophy in HIV Infection.
    Clin Infect Dis. 2017 Feb 24. doi: 10.1093.
    PubMed     Text format     Abstract available

  40. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available

  41. COLLIER D, Iwuji C, Derache A, de Oliveira T, et al
    Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  42. NAGGIE S, Marks KM, Hughes M, Fierer DS, et al
    Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
    Clin Infect Dis. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  43. JAMIESON L, Evans D, Brennan AT, Moyo F, et al
    Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.
    HIV Med. 2017 Mar 23. doi: 10.1111/hiv.12495.
    PubMed     Text format     Abstract available

  44. TI L, Dong H, Kerr T, Turje RB, et al
    The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
    HIV Med. 2017 Mar 19. doi: 10.1111/hiv.12493.
    PubMed     Text format     Abstract available


    Int J Dermatol

  45. HANDLER NS, Handler MZ, Stephany MP, Handler GA, et al
    Porphyria cutanea tarda: an intriguing genetic disease and marker.
    Int J Dermatol. 2017 Mar 21. doi: 10.1111/ijd.13580.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  46. MAHESWARAN H, Petrou S, MacPherson P, Kumwenda F, et al
    Economic costs and health-related quality of life outcomes of HIV treatment following self- and facility-based HIV testing in a cluster randomised trial.
    J Acquir Immune Defic Syndr. 2017 Mar 21. doi: 10.1097/QAI.0000000000001373.
    PubMed     Text format     Abstract available

  47. MUKERJI SS, Misra V, Lorenz D, Cervantes-Arslanian AM, et al
    Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-experienced HIV-1 Infected Adults.
    J Acquir Immune Defic Syndr. 2017 Mar 21. doi: 10.1097/QAI.0000000000001362.
    PubMed     Text format     Abstract available

  48. LEVINE AJ, Martin E, Sacktor N, Munro C, et al
    Predictors and impact of self-reported suboptimal effort on estimates of prevalence of HIV-associated neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001371.
    PubMed     Text format     Abstract available

  49. SIVAY MV, Li M, Piwowar-Manning E, Zhang Y, et al
    Characterization of HIV seroconverters in a TDF/FTC PrEP study: HPTN 067/ADAPT.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001374.
    PubMed     Text format     Abstract available

  50. ZHOU RH, Guo L, Liu JB, Liu H, et al
    Epigallocatechin gallate inhibits macaque SEVI-mediated enhancement of SIV or SHIV infection.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001361.
    PubMed     Text format     Abstract available

  51. MORGAN E, Nyaku AN, D'Aquila RT, Schneider JA, et al
    Determinants of HIV phylogenetic clustering in Chicago among young black men who have sex with men from the uConnect cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001379.
    PubMed     Text format     Abstract available

  52. MERLIN JS, Westfall AO, Heath SL, Goodin BR, et al
    IL-1beta levels are associated with chronic multisite pain in people living with HIV.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001377.
    PubMed     Text format     Abstract available

  53. REID MJ, Baxi SM, Sheira LA, Landay AL, et al
    Higher Body Mass Index is Associated with Greater Proportions of Effector CD8+ T cells Expressing CD57 in Women Living with HIV.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001376.
    PubMed     Text format     Abstract available

  54. CEPEDA JA, Solomon SS, Srikrishnan AK, McFall AM, et al
    Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001372.
    PubMed     Text format     Abstract available


    J Infect Dis

  55. TER KUILE FO, Taylor SM
    Gilding the lily?: Enhancing antenatal malaria prevention in HIV-infected women.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format    

  56. DING Y, Lin H, Liu X, Wong FY, et al
    Higher Prevalence of Frailty Among a Sample of HIV-Infected Middle-aged and Older Chinese Adults Is Associated With Neurocognitive Impairment and Depressive Symptoms.
    J Infect Dis. 2017 Mar 16. doi: 10.1093.
    PubMed     Text format     Abstract available

  57. PHILLIPS AN, Stover J, Cambiano V, Nakagawa F, et al
    Impact of HIV drug resistance on HIV/AIDS associated mortality, new infections and antiretroviral therapy program costs in sub-Saharan Africa.
    J Infect Dis. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  58. CELUM C, Hong T, Cent A, Donnell D, et al
    HSV-2 acquisition among HIV-1 infected adults treated with tenofovir as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available

  59. LEE S, Byakwaga H, Boum Y, Burdo TH, et al
    Immunologic Pathways that Predict Mortality in HIV-Infected Ugandans Initiating ART.
    J Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available

  60. LOFGREN S, Hullsiek KH, Morawski BM, Nabeta HW, et al
    Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available

  61. NATUREEBA P, Kakuru A, Muhindo M, Littmann E, et al
    Intermittent Preventive Treatment with Dihydroartemisinin-piperaquine for the Prevention of Malaria among HIV-infected Pregnant Women.
    J Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format     Abstract available

  62. MARGOT NA, Wong P, Kulkarni R, White K, et al
    Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse Transcriptase and Protease in Antiretroviral Treatment-Naive Patients do not Affect Response to Tenofovir Disoproxil Fumarate- or Tenofovir Alafenamide-Containing Regimens.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available

  63. WYLES D, Saag M, Viani RM, Lalezari J, et al
    TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
    J Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  64. COMAR M, Seraceni S, Colli C, Luska V, et al
    Chlamydia trachomatis and HPV co-infections in HIV negative men from a multi-ethnic area of Northern Italy at high prevalence of cervical malignancies.
    J Med Virol. 2017 Mar 18. doi: 10.1002/jmv.24811.
    PubMed     Text format     Abstract available


    J Virol

  65. CUMMINS NW, Sainski-Nguyen AM, Natesampillai S, Aboulnasr F, et al
    Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition.
    J Virol. 2017 Mar 22. pii: JVI.00012-17. doi: 10.1128/JVI.00012.
    PubMed     Text format     Abstract available

  66. YOSHIKAWA R, Takeuchi JS, Yamada E, Nakano Y, et al
    Feline immunodeficiency virus evolutionarily acquires two proteins, Vif and protease, capable of antagonizing feline APOBEC3.
    J Virol. 2017 Mar 22. pii: JVI.00250-17. doi: 10.1128/JVI.00250.
    PubMed     Text format     Abstract available

  67. PETERLIN BM, Liu P, Wang X, Cary D, et al
    Hili inhibits HIV replication in activated T cells.
    J Virol. 2017 Mar 22. pii: JVI.00237-17. doi: 10.1128/JVI.00237.
    PubMed     Text format     Abstract available

  68. RICHARD J, Prevost J, von Bredow B, Ding S, et al
    BST-2 Expression Modulates Small CD4 Mimetic Sensitization of HIV-1-infected cells to ADCC.
    J Virol. 2017 Mar 22. pii: JVI.00219-17. doi: 10.1128/JVI.00219.
    PubMed     Text format     Abstract available


    JAMA

  69. FRIEDRICH MJ
    Cervicovaginal Bacteria May Influence HIV Risk.
    JAMA. 2017;317:1109.
    PubMed     Text format    


    Lancet

  70. DANIELS JP
    Venezuela's economic crisis hampers HIV/AIDS treatment.
    Lancet. 2017;389:1088-1089.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  71. GELDSETZER P, Manne-Goehler J, Barnighausen T, Davies JI, et al
    What research is needed to address the co-epidemics of HIV and cardiometabolic disease in sub-Saharan Africa?
    Lancet Diabetes Endocrinol. 2017 Mar 17. pii: S2213-8587(17)30091.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  72. TSANG CA, Langer AJ, Navin TR, Armstrong LR, et al
    Tuberculosis Among Foreign-Born Persons Diagnosed >/=10 Years After Arrival in the United States, 2010-2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:295-298.
    PubMed     Text format     Abstract available


    Nature

  73. DOITSH G, Galloway NL, Geng X, Yang Z, et al
    Corrigendum: Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.
    Nature. 2017 Mar 22. doi: 10.1038/nature22066.
    PubMed     Text format    


    Pediatr Infect Dis J

  74. BELARD S, Heller T, Orie V, Heuvelings CC, et al
    Sonographic Findings of Abdominal Tuberculosis in Children with Pulmonary Tuberculosis.
    Pediatr Infect Dis J. 2017 Mar 22. doi: 10.1097/INF.0000000000001590.
    PubMed     Text format     Abstract available


    PLoS One

  75. GORBACH PM, Javanbakht M, Bornfleth L, Bolan RK, et al
    Drug resistant HIV: Behaviors and characteristics among Los Angeles men who have sex with men with new HIV diagnosis.
    PLoS One. 2017;12:e0173892.
    PubMed     Text format     Abstract available

  76. GUPTA N, Kabahizi J, Mukabatsinda C, Walker TD, et al
    "Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
    PLoS One. 2017;12:e0174148.
    PubMed     Text format     Abstract available

  77. RALLON N, Garcia M, Garcia-Samaniego J, Rodriguez N, et al
    HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    PLoS One. 2017;12:e0173943.
    PubMed     Text format     Abstract available

  78. COHEN CR, Grossman D, Onono M, Blat C, et al
    Integration of family planning services into HIV care clinics: Results one year after a cluster randomized controlled trial in Kenya.
    PLoS One. 2017;12:e0172992.
    PubMed     Text format     Abstract available

  79. LU W, Wan Y, Ma F, Johnson RP, et al
    Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVDeltanef live attenuated vaccine.
    PLoS One. 2017;12:e0173929.
    PubMed     Text format     Abstract available

  80. IWAMOTO A, Taira R, Yokomaku Y, Koibuchi T, et al
    The HIV care cascade: Japanese perspectives.
    PLoS One. 2017;12:e0174360.
    PubMed     Text format     Abstract available

  81. PINCHOFF J, Boyer CB, Mutombo N, Chowdhuri RN, et al
    Why don't urban youth in Zambia use condoms? The influence of gender and marriage on non-use of male condoms among young adults.
    PLoS One. 2017;12:e0172062.
    PubMed     Text format     Abstract available

  82. KELLY HA, Ngou J, Chikandiwa A, Sawadogo B, et al
    Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.
    PLoS One. 2017;12:e0174117.
    PubMed     Text format     Abstract available

  83. SEDEN K, Gibbons S, Marzolini C, Schapiro JM, et al
    Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.
    PLoS One. 2017;12:e0173509.
    PubMed     Text format     Abstract available

  84. KARAT AS, Tlali M, Fielding KL, Charalambous S, et al
    Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data.
    PLoS One. 2017;12:e0174097.
    PubMed     Text format     Abstract available

  85. HATTHAKAROON C, Pharkjaksu S, Chongtrakool P, Suwannakarn K, et al
    Molecular epidemiology of cryptococcal genotype VNIc/ST5 in Siriraj Hospital, Thailand.
    PLoS One. 2017;12:e0173744.
    PubMed     Text format     Abstract available


    PLoS Pathog

  86. TENFORDE MW, Scriven JE, Harrison TS, Jarvis JN, et al
    Immune correlates of HIV-associated cryptococcal meningitis.
    PLoS Pathog. 2017;13:e1006207.
    PubMed     Text format    

  87. MOUSTAFA A, Xie C, Kirkness E, Biggs W, et al
    The blood DNA virome in 8,000 humans.
    PLoS Pathog. 2017;13:e1006292.
    PubMed     Text format     Abstract available

  88. BUI JK, Sobolewski MD, Keele BF, Spindler J, et al
    Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir.
    PLoS Pathog. 2017;13:e1006283.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  89. MEDLOCK J, Pandey A, Parpia AS, Tang A, et al
    Effectiveness of UNAIDS targets and HIV vaccination across 127 countries.
    Proc Natl Acad Sci U S A. 2017 Mar 20. pii: 201620788.
    PubMed     Text format     Abstract available


    Vaccine

  90. HUANG X, Zhu Q, Huang X, Yang L, et al
    In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Vaccine. 2017 Mar 16. pii: S0264-410X(17)30312.
    PubMed     Text format     Abstract available

  91. VAN REGENMORTEL MH
    Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30323.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: